| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quantum-Si Inc | Chief Financial Officer | Class A Common Stock | 447K | $388K | $0.87 | Aug 9, 2024 | Direct |
| CNS Pharmaceuticals, Inc. | Director | Restricted Stock Units | 80.4K | $24.1K | $0.30 | Apr 8, 2024 | Direct |
| CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 62.9K | Apr 8, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QSI | Quantum-Si Inc | Aug 9, 2024 | 1 | $43.5K | 4 | Aug 13, 2024 | Chief Financial Officer |
| CNSP | CNS Pharmaceuticals, Inc. | Apr 8, 2024 | 2 | $0 | 4 | Apr 10, 2024 | Director |
| QSI | Quantum-Si Inc | Mar 15, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Chief Financial Officer |
| QSI | Quantum-Si Inc | Mar 5, 2024 | 1 | $80.5K | 4 | Mar 6, 2024 | Chief Financial Officer |
| CNSP | CNS Pharmaceuticals, Inc. | Sep 21, 2023 | 1 | $0 | 4/A | Oct 12, 2023 | Director |
| QSI | Quantum-Si Inc | May 15, 2023 | 3 | $0 | 4 | May 16, 2023 | Chief Financial Officer |
| QSI | Quantum-Si Inc | May 15, 2023 | 0 | $0 | 3 | May 16, 2023 | Chief Financial Officer |
| CNSP | CNS Pharmaceuticals, Inc. | Mar 7, 2022 | 1 | $3.29K | 4 | Mar 9, 2022 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 16, 2021 | Director |